TYPE2 DIABETES

This study tested a new medicine called efsubaglutide alfa in 59 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received an injection every two weeks for 12 weeks. The goal was to see if it safely lowers blood sugar …

This study tested whether a special light treatment could help people with mild cognitive impairment or early Alzheimer's disease. The goal was to see if it could improve thinking, sleep, and metabolism. Twenty-five people who lived at home and had sleep problems took part. The s…

This study looked at how evolocumab (Repatha) affects markers of inflammation and blood clotting in 41 people with type 2 diabetes and heart or blood vessel disease. Participants received either evolocumab or a placebo injection every 4 weeks for 3 doses. The goal was to understa…

This study looked at how low blood sugar (hypoglycemia) affects the body's ability to control heart rate in people with well-controlled type 2 diabetes. Researchers measured changes in baroreflex sensitivity—a key heart rate regulator—before and after inducing low blood sugar. Th…

This study looked at whether a type of talk therapy (cognitive-behavioral therapy) could improve how the body uses insulin in teenage girls at risk for type 2 diabetes. The girls were 12-17 years old, overweight, had mild to moderate depression, and a family history of diabetes. …

This small pilot study looked at whether taking metformin before a meal (30 or 60 minutes prior) affects how the body absorbs carbohydrates. Researchers tested this in one obese person with prediabetes or type 2 diabetes using sugar-drink tests. The goal was to understand if timi…

This study looked at 210 women who had gestational diabetes during pregnancy, about 8 years after giving birth. Researchers measured blood sugar, insulin, weight, and lifestyle factors to understand who later develops type 2 diabetes. No treatment was given; the goal was to learn…